Literature DB >> 6894077

Gastrointestinal and disseminated candidiasis. An experimental model in the immunosuppressed rat.

R L Myerowitz.   

Abstract

An experimental model of invasive gastrointestinal (GI) candidiasis was studied in immunosuppressed rats. Normal rats were susceptible to disseminated candidiasis by intravascular inoculation (lethal dose for 50% survival [LD50], 1.6 x 10(6) blastospores). Cyclophosphamide-induced leukopenia decreased the LD50 to 1.2 x 10(4) blastospores. Feeding Candida albicans to rats resulted in low-grade GI colonization of normal rats. The intensity of colonization was increased by treatment with cyclophosphamide and broad-spectrum antibiotics. Only in animals fed Candida and treated with both antibiotics and cyclophosphamide did invasive GI lesions develop. However, hematogenous dissemination occurred in only about 10% of such rats. The addition of cortisone acetate to the treatment regimen increased the frequency of hematogenous dissemination to about 25%. Thus, disseminated candidiasis after invasive GI disease can be produced in the rat after exposure to the same predisposing factors as immunosuppressed human patients in whom the disease develops.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894077

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata.

Authors:  M A Ghannoum
Journal:  Mycopathologia       Date:  1986-09       Impact factor: 2.574

Review 3.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

4.  Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis.

Authors:  M E Bougnoux; C Hill; D Moissenet; M Feuilhade de Chauvin; M Bonnay; I Vicens-Sprauel; F Pietri; M McNeil; L Kaufman; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

5.  Gastric colonization with Candida albicans.

Authors:  R A Greenfield; W A Joyce
Journal:  Mycopathologia       Date:  1993-04       Impact factor: 2.574

6.  Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis.

Authors:  G T Cole; K Saha; K R Seshan; K T Lynn; M Franco; P K Wong
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Comparison of antibody, antigen, and metabolite assays in rat models of systemic and gastrointestinal candidiasis.

Authors:  R A Greenfield; D L Troutt; R C Rickard; D H Altmiller
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

8.  Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice.

Authors:  J R Wingard; J D Dick; W G Merz; G R Sandford; R Saral; W H Burns
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

Review 10.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.